The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

BloombergNEF says in a new report that global clean energy investment reached $2.1 trillion in 2024, more than doubling 2020 ...

Infinity is going public after more than doubling its revenue in the first nine months of 2024. The strong growth came as the ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...

A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

Bond manager’s $7 billion stake in Venture Global latest sign that traditional asset managers are making inroads investing in ...

Baker Hughes has been awarded a major contract to provide a modularised liquefied natural gas (LNG) system and power island to support Venture Global (VG) LNG projects in the US.